These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3145780)
1. Sodium valproate decreases synaptic potentiation and epileptiform activity in hippocampus. Griffith WH; Taylor L Brain Res; 1988 Nov; 474(1):155-64. PubMed ID: 3145780 [TBL] [Abstract][Full Text] [Related]
2. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. McLean MJ; Macdonald RL J Pharmacol Exp Ther; 1986 Jun; 237(3):1001-11. PubMed ID: 3086538 [TBL] [Abstract][Full Text] [Related]
3. Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro. Hanaya R; Sasa M; Ujihara H; Ishihara K; Serikawa T; Iida K; Akimitsu T; Arita K; Kurisu K Brain Res; 1998 Apr; 789(2):274-82. PubMed ID: 9573382 [TBL] [Abstract][Full Text] [Related]
4. Repeated tetanic stimulation in piriform cortex in vitro: epileptogenesis and pharmacology. Pelletier MR; Carlen PL J Neurophysiol; 1996 Dec; 76(6):4069-79. PubMed ID: 8985901 [TBL] [Abstract][Full Text] [Related]
5. Phenytoin reduces excitatory synaptic transmission and post-tetanic potentiation in the in vitro hippocampus. Griffith WH; Taylor L J Pharmacol Exp Ther; 1988 Sep; 246(3):851-8. PubMed ID: 2843632 [TBL] [Abstract][Full Text] [Related]
6. Picrotoxin-induced epileptiform activity in hippocampus: role of endogenous versus synaptic factors. Hablitz JJ J Neurophysiol; 1984 May; 51(5):1011-27. PubMed ID: 6327932 [TBL] [Abstract][Full Text] [Related]
7. Epileptiform activity induced by changes in extracellular potassium in hippocampus. Rutecki PA; Lebeda FJ; Johnston D J Neurophysiol; 1985 Nov; 54(5):1363-74. PubMed ID: 2416891 [TBL] [Abstract][Full Text] [Related]
8. 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. Rutecki PA; Lebeda FJ; Johnston D J Neurophysiol; 1987 Jun; 57(6):1911-24. PubMed ID: 3037040 [TBL] [Abstract][Full Text] [Related]
9. Valproate reduced synaptic activity increase induced by 4-aminopyridine at the hippocampal CA3-CA1 synapse. Martín ED; Pozo MA Epilepsia; 2004 May; 45(5):436-40. PubMed ID: 15101824 [TBL] [Abstract][Full Text] [Related]
10. Chloride-cotransport blockade desynchronizes neuronal discharge in the "epileptic" hippocampal slice. Hochman DW; Schwartzkroin PA J Neurophysiol; 2000 Jan; 83(1):406-17. PubMed ID: 10634883 [TBL] [Abstract][Full Text] [Related]
11. Rapid plasticity at inhibitory and excitatory synapses in the hippocampus induced by ictal epileptiform discharges. Lopantsev V; Both M; Draguhn A Eur J Neurosci; 2009 Mar; 29(6):1153-64. PubMed ID: 19302151 [TBL] [Abstract][Full Text] [Related]
12. A role for synaptic and network plasticity in controlling epileptiform activity in CA1 in the kainic acid-lesioned rat hippocampus in vitro. Bernard C; Wheal HV J Physiol; 1996 Aug; 495 ( Pt 1)(Pt 1):127-42. PubMed ID: 8866357 [TBL] [Abstract][Full Text] [Related]
13. Local circuit abnormalities in chronically epileptic rats after intrahippocampal tetanus toxin injection in infancy. Smith KL; Lee CL; Swann JW J Neurophysiol; 1998 Jan; 79(1):106-16. PubMed ID: 9425181 [TBL] [Abstract][Full Text] [Related]
14. Voltage-clamp analysis of posttetanic potentiation of the mossy fiber to CA3 synapse in hippocampus. Griffith WH J Neurophysiol; 1990 Mar; 63(3):491-501. PubMed ID: 2158522 [TBL] [Abstract][Full Text] [Related]
15. Trans-2-en-valproic acid limits action potential firing frequency in mouse central neurons in cell culture. Wamil AW; Loscher W; McLean MJ J Pharmacol Exp Ther; 1997 Mar; 280(3):1349-56. PubMed ID: 9067323 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. Tallent MK; Siggins GR J Neurophysiol; 1999 Apr; 81(4):1626-35. PubMed ID: 10200199 [TBL] [Abstract][Full Text] [Related]
17. Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CA1 hippocampal pyramidal cells maintained 'in vitro'. Perreault P; Tancredi V; Avoli M Epilepsy Res; 1989; 3(3):227-31. PubMed ID: 2499451 [TBL] [Abstract][Full Text] [Related]
18. Epileptiform activity in the hippocampus produced by tetraethylammonium. Rutecki PA; Lebeda FJ; Johnston D J Neurophysiol; 1990 Oct; 64(4):1077-88. PubMed ID: 2258736 [TBL] [Abstract][Full Text] [Related]
19. Comparison of effects of valproate and trans-2-en-valproate on different forms of epileptiform activity in rat hippocampal and temporal cortex slices. Sokolova S; Schmitz D; Zhang CL; Löscher W; Heinemann U Epilepsia; 1998 Mar; 39(3):251-8. PubMed ID: 9578041 [TBL] [Abstract][Full Text] [Related]
20. Low magnesium epileptogenesis in the rat hippocampal slice: electrophysiological and pharmacological features. Tancredi V; Hwa GG; Zona C; Brancati A; Avoli M Brain Res; 1990 Mar; 511(2):280-90. PubMed ID: 1970748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]